Friday, April 9, 2021

US FDA News: FDA Authorizes Marketing of First Device that Uses Artificial Intelligence to Help Detect Potential Signs of Colon Cancer

FDA authorized marketing of the GI Genius, the first device that uses artificial intelligence based on machine learning to detect lesions in the colon in real time during a colonoscopy.
Read more: FDA Authorizes Marketing of First Device that Uses Artificial Intelligence to Help Detect Potential Signs of Colon Cancer